221684-52-2

Basic information

• Product Name: Benzoic acid, 3-(benzoyloxy)-2-hydroxy-, methyl ester
• CAS NO: 221684-52-2
• Molecular Formula: C15H12O5
• Molecular Weight: 272.257
• Mol File: 221684-52-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 3-(benzoyloxy)-2-hydroxy-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 3-(benzoyloxy)-2-hydroxy-, methyl ester(221684-52-2)
• EPA Substance Registry System: Benzoic acid, 3-(benzoyloxy)-2-hydroxy-, methyl ester(221684-52-2)

Safety Data

• Hazardous Substances Data: 221684-52-2(Hazardous Substances Data)

Upstream product

• 303-38-8 2,3-Dihydroxybenzoic acid 
• 2411-83-8 methyl-2,3-dihydroxybenzoate 
• 98-88-4 benzoyl chloride 

Downstream Products

• 838857-95-7 2-chloro-4-(6-fluoro-1-methyl-8,9-bis{[2-(methyloxy)ethyl]oxy}-3H-pyrazolo[3,4-c]isoquinolin-5-yl)phenol hydrochloride 
• 838858-06-3 4-(5-fluoro-2,3-bis{[2-(methyloxy)ethyl]oxy}phenyl)-3-methyl-1H-pyrazol-5-amine 
• 838857-97-9 methyl 2-{[2-(methyloxy)ethyl]oxy}-5-nitro-3-[(phenylcarbonyl)oxy]benzoate 
• 838857-79-7 methyl 2-[(2-bromoethyl)oxy]-5-nitro-3-[(phenylcarbonyl)oxy]benzoate 
• 838858-05-2 2-(5-fluoro-2,3-bis{[2-(methyloxy)ethyl]oxy}phenyl)-3-oxobutanenitrile 
• 838857-99-1 methyl 2,3-bis{[2-(methyloxy)ethyl]oxy}-5-nitrobenzoate 
• 838858-00-7 methyl 5-amino-2,3-bis{[2-(methyloxy)ethyl]oxy}benzoate 
• 838858-04-1 (5-fluoro-2,3-bis{[2-(methyloxy)ethyl]oxy}phenyl)acetonitrile 
• 838858-03-0 1-(chloromethyl)-5-fluoro-2,3-bis{[2-(methyloxy)ethyl]oxy}benzene 
• 838858-01-8 methyl 5-fluoro-2,3-bis{[2-(methyloxy)ethyl]oxy}benzoate 
• 838858-02-9 (5-fluoro-2,3-bis{[2-(methyloxy)ethyl]oxy}phenyl)methanol 
• 838857-98-0 methyl 3-hydroxy-2-{[2-(methyloxy)ethyl]oxy}-5-nitrobenzoate 
• 838857-78-6 methyl 2-[(2-bromoethyl)oxy]-3-[(phenylcarbonyl)oxy]benzoate 
• 838857-96-8 methyl 2-{[2-(methyloxy)ethyl]oxy}-3-[(phenylcarbonyl)oxy]benzoate 

Relevant articles and documents

ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE

The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological disorders, cardiovascular diseases, and other degenerative disorders.